Streetbeat News

Stock Prices

EWZ

USO

BP Energy has successfully won an oil auction for the concession of the Tupinamba area in Brazil's Santos Basin, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:45 pm

BITF

BTBT

CLSK

HIVE

MARA

RIOT

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:45 pm

CCCC

DESP

RSLS

STTK

TTWO

Despegar.com, Corp. (DESP) shares rose by 16.4% after raising its FY23 revenue guidance. Other stocks moved in Wednesday's mid-day session with significant gainers including Shattuck Labs (STTK), ReShape Lifesciences (RSLS), and C4 Therapeutics (CCCC), among others. Losers included Hywin Holdings (HYW), Boqii Holding (BQ), and Processa Pharmaceuticals (PCSA). Notable mentions include ABM Industries (ABM) with positive results and guidance, and Take-Two Interactive Software (TTWO) being added to the Nasdaq-100 Index.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 6:40 pm

ETH-USD

MATIC-USD

SPY

Former President Donald Trump's NFT collections have seen significant returns since their launch. The first collection, minted on the Polygon network and sold for $99 each, has appreciated to a value of $3,517.90 from an initial $1,000 investment, a 251.8% return in 12 months. This outperforms the S&P 500's 19.9% return over the same period. The second series of NFTs has not fared as well, with a current floor price resulting in a 35.8% loss for investors. A third 'MugShot Edition' collection has been announced, with a unique physical card component for bulk buyers and restrictions on transfer until December 31, 2024.

Portfolio Pulse from Chris Katje

December 13, 2023 | 6:39 pm

A significant options trade was detected for WW International, with a sweep of 1000 Jan 19 $7.5 call options at $0.95 each, compared to an open interest of 13956. The stock reference price at the time was $7.12.

Portfolio Pulse from Charles Gross

December 13, 2023 | 6:35 pm

ARCT

CSLLY

Canaccord Genuity initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) with a bullish rating, citing the company's proprietary LNP delivery tech and mRNA cargos. They are particularly optimistic about ARCT-032, a cystic fibrosis treatment, which is in Phase 1b trials with interim data expected in H1 2024. A positive outcome could significantly revalue the program. Canaccord set a price target of $81, indicating over 200% upside. Arcturus is also advancing ARCT-810 for OTC deficiency, with Phase 2 trial enrollment underway. Additionally, ARCT-154, a COVID-19 vaccine developed with CSL Ltd (OTC:CSLLY), was approved in Japan. ARCT shares rose 4.07% to $24.29.

Portfolio Pulse from Vandana Singh

December 13, 2023 | 6:34 pm

NKLA

A significant number of Nikola Corporation put options were traded at the bid price. Specifically, 25,000 contracts for January 19th $2 puts were purchased at $1.29 each, compared to an open interest of 78,302 contracts. This activity occurred with Nikola's stock reference price at $0.7256.

Portfolio Pulse from Charles Gross

December 13, 2023 | 6:31 pm

MRNA

Moderna Inc (NASDAQ:MRNA) stock fell by 4.5% to $74.50 amid a broader sell-off in COVID vaccine stocks triggered by Pfizer Inc.'s FY24 guidance, which was below consensus estimates. Pfizer's guidance included projections from the Seagen Inc acquisition. Investors are reassessing expectations for companies like Moderna, leading to a decline in their stock prices. Moderna has a 52-week range between $217.25 and $62.55.

Portfolio Pulse from Henry Khederian

December 13, 2023 | 6:30 pm

ALGT

Raymond James analyst Savanthi Syth has maintained an Outperform rating on Allegiant Travel (NASDAQ:ALGT) but reduced the price target from $118 to $110.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:30 pm

AAPL

AMZN

FWONA

FWONK

NFLX

Netflix Inc (NASDAQ:NFLX) is expanding into live sports, leveraging the success of its sports docuseries. The company announced 'The Netflix Slam,' a tennis match between Rafael Nadal and Carlos Alcaraz, to be streamed live on March 3, 2024. Netflix's sports docuseries have been successful, with 'Drive to Survive' contributing to the growth of Formula 1 in the U.S. Netflix's engagement report shows significant viewership hours for its sports series. The company is exploring live content, following in the footsteps of Amazon.com, Inc. (NASDAQ:AMZN) and Apple Inc (NASDAQ:AAPL), but focusing on smaller sports rights and live specials rather than costly major sports rights.

Portfolio Pulse from Chris Katje

December 13, 2023 | 6:24 pm